Mô tả

Renal function and kidney disease progression data for EPA versus DHA reveal potential differences in nephroprotective mechanisms.

Figure 22

Source Paper

Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?

Nutrients (2020)

PMID: 33276463

DOI: 10.3390/nu12123718

Cite This Figure

![Figure 22: Renal function and kidney disease progression data for EPA versus DHA reveal potential differences in nephroprotective mechanisms.]()

> Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." *Nutrients*, 2020. PMID: [33276463](https://pubmed.ncbi.nlm.nih.gov/33276463/)

<figure>
  <img src="" alt="Renal function and kidney disease progression data for EPA versus DHA reveal potential differences in nephroprotective mechanisms." />
  <figcaption>Figure 22. Renal function and kidney disease progression data for EPA versus DHA reveal potential differences in nephroprotective mechanisms.<br>  Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33276463/">33276463</a></figcaption>
</figure>

Bằng chứng liên quan

Omega-3 Fatty Acids (EPA/DHA) cho Chronic Inflammation

Xếp hạng A · 30 nghiên cứu